PATENT CLAIM ANALYSIS

Application Number: 15884036
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["514", "185000"]

Abstract:
Metal-organic frameworks (MOFs) comprising photosensitizers are described. The MOFs can also include moieties capable of absorbing X-rays or other ionizing irradiation energy and/or scintillation. Optionally, the photosensitizer or a derivative thereof can form a bridging ligand of the MOF. Further optionally, the MOF can comprise inorganic nanoparticles in the cavities or channels of the MOF or can be used in combination with an inorganic nanoparticle. Also described are methods of using MOFs and/or inorganic nanoparticles in photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, or in radiotherapy-radiodynamic therapy, either with or without the co-administration of one or more immunotherapeutic agent and/or one or more chemotherapeutic agent.

Claim (Index 3):
The composition of  claim 1 , wherein each of the one or more bridging ligands comprises an organic compound capable of binding to two or three SBUs.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 86.0
- Lexical Diversity: 1.75362
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15518665', '15129853', '15129851', '15034799', '15116186']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6690071762140444
- 35 USC 102 Novelty (BERT): 0.6900673709849691
- Combined Prediction Score: 0.6711131956911369
- Mean Citation Score: 359.849256
- Max Citation Score: 770.5269
- Similarity Product: 655.1273660170912

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test